BN Business News
Add your company to Business Communicator →

BUSINESS NEWS

Search Business News

Find articles by title or summary.

5/30/2025

FDA Clears COREG CR Extended-Release Capsules for Continued Sale

The FDA has determined that COREG CR, a medication used to treat high blood pressure and heart failure, will not be withdrawn from sale due to safety or effectiveness concerns, allowing its continued approval for use in abbreviated new drug applications.

5/30/2025

FDA Clears Way for ursodiol Capsule Approval

The FDA has determined that the 150mg ACTIGALL (ursodiol) capsule was not withdrawn from sale due to safety or effectiveness concerns, paving the way for potential approval of abbreviated new drug applications.

5/30/2025

USDA Amends Tobacco Price Support Regulations

The US Department of Agriculture (USDA) has rescinded regulations related to tobacco price support services, aligning with the Fair and Equitable Tobacco Reform Act of 2004 and Executive Order 14192, which eliminated the price support and quota system for US-grown tobacco.

5/29/2025

Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly; Correction

This document corrects technical errors in the final rule that appeared in the April 15, 2025 Federal Register, titled 'Medicare and Medicaid Programs; Contract Year 2026 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, Medicare Cost Plan Program, and Programs of All-Inclusive Care for the Elderly'.

5/29/2025

Proposed Agency Information Collection Activities; Comment Request

The Federal Railroad Administration (FRA) is forwarding an Information Collection Request (ICR) to the Office of Management and Budget (OMB) for review and comment, following a 60-day public comment period that ended on March 25, 2025, with no comments received.

5/29/2025

Self-Regulatory Organizations; Cboe Exchange, Inc.; Notice of Filing of Amendment No. 1 and Order Granting Accelerated Approval of a Proposed Rule Change, as Modified by Amendment No. 1, To Permit the Exchange To List and Trade Options With P.M.-Settlement That Overlie the S&P 500 Equal Weight Index

The Cboe Exchange, Inc. has filed an amendment to a proposed rule change, which was granted accelerated approval, to permit the exchange to list and trade options with P.M.-settlement that overlie the S&P 500 Equal Weight Index.

5/29/2025

Self-Regulatory Organizations; Cboe BZX Exchange, Inc.; Order Instituting Proceedings To Determine Whether To Approve or Disapprove a Proposed Rule Change To Amend the Rules Governing the Listing and Trading of Shares of the Fidelity Wise Origin Bitcoin Fund and the Fidelity Ethereum Fund To Permit In-Kind Creations and Redemptions Under Rule 14.11(e)(4) (Commodity-Based Trust Shares)

The Cboe BZX Exchange, Inc. has proposed a rule change to amend the rules governing the listing and trading of shares of the Fidelity Wise Origin Bitcoin Fund and the Fidelity Ethereum Fund to permit in-kind creations and redemptions.